ARYX THERAPEUTICS I ARYX (NASDAQ)

$ 5.90
19:09
Change: -0.22 (-3.59%)
Volume: 2,900

Avg. Volume: 5055
P/E Ratio: 0
EPS (Annual): -8.31
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 17,670
Institutional Shareholders: 33.71%
Last: 5.90
Change: -0.22 (-3.59%)
Prev. Close: 6.12
Open: 6.57
Day's Range: 5.83 - 6.57
52wk Range: 4.18 - 9.74
Market Value: 108,220
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: -27.16%
Total Return Last 3 Years: -27.16%
Total Return Last 5 Years: -27.16%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on ARYX

Amgen executive joins Aryx Therapeutics board

(FREMONT, Calif.)Biotech drug developer Aryx Therapeutics Inc. on Friday said Amgen executive David Beier has joined its board of directors. Beier handles government relations and corporate communi...READ MORE
Aug 29, 2008 1:05PM
Keywords: ARYX

Aryx shares fall as P&G pulls out of partnership

(NEW YORK)Shares of Biotechnology company Aryx Therapeutics Inc. fell Thursday after Procter & Gamble abruptly ended its partnership on a developing gastrointestinal disorder drug.READ MORE
Jul 03, 2008 5:11PM
Keywords: ARYX, PG

Procter & Gamble pulls out of Aryx partnership

(NEW YORK)Biotechnology company Aryx Therapeutics Inc. said Wednesday Procter & Gamble abruptly pulled out of a partnership on a developing gastrointestinal disorder drug, despite positive s...READ MORE
Jul 02, 2008 5:46PM
Keywords: ARYX, PG

Aryx skipping conference because of study analysis

(FREMONT, Calif.)Aryx Therapeutics Inc. said Monday an ongoing analysis of study results for its gastrointestinal disorder treatment candidate will prevent it from attending an upcoming investor co...READ MORE
Jun 23, 2008 5:59PM
Keywords: ARYX
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +28.80 60.41
AMYLIN PHARMA I -56.90 21.11
GILEAD SCIENCES +15.20 47.85
BIOGEN IDEC INC -20.40 48.59
GENENTECH INC +33.90 96.64